HISTAMINUM HYDROCHLORICUM

HISTAMINUM HYDROCHLORICUM was reported 3902 times

HISTAMINUM HYDROCHLORICUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMOSIDERINURIA 1 0.1667
1 TRACE ELEMENT DEFICIENCY 1 0.0769
2 LEFT VENTRICULAR OUTFLOW TRACT GRADIENT INCREASED 2 0.0294
3 TRANSVALVULAR PRESSURE GRADIENT INCREASED 1 0.0233
4 HUNTINGTON'S DISEASE 1 0.0189
5 HISTAMINE INTOLERANCE 4 0.0176
6 CAFFEINE ALLERGY 1 0.0161
7 CARBOHYDRATE INTOLERANCE 1 0.0147
8 FASTING 1 0.0133
9 CATHETER SITE DISCOMFORT 1 0.0125
10 FATTY ACID DEFICIENCY 1 0.0122
11 FRUCTOSE INTOLERANCE 1 0.0111
12 OXIDATIVE STRESS 1 0.0106
13 CONNECTIVE TISSUE INFLAMMATION 1 0.0105
14 ARTIFICIAL MENOPAUSE 1 0.0094
15 BLOOD ZINC DECREASED 1 0.0055
16 SIGHT DISABILITY 1 0.0053
17 ABNORMAL CLOTTING FACTOR 1 0.0049
18 HISTAMINE LEVEL INCREASED 1 0.0046
19 ALLERGIC COUGH 3 0.0039
20 VAGINAL ABSCESS 1 0.0037
21 APPLICATION SITE MASS 1 0.0036
22 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 1 0.0032
23 VAGINAL DISORDER 3 0.0031
24 DUST ALLERGY 3 0.0031
25 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
26 KERATOCONJUNCTIVITIS SICCA 1 0.0027
27 LUNG ADENOCARCINOMA STAGE IV 1 0.0026
28 ELECTROCARDIOGRAM T WAVE PEAKED 1 0.0025
29 CHLOASMA 1 0.0022
30 ELECTROLYTE DEPLETION 1 0.0020
31 SALIVARY GLAND CANCER 1 0.0020
32 FAECAL VOLUME INCREASED 1 0.0019
33 CATHETER SITE INFLAMMATION 1 0.0018
34 COLLAGEN DISORDER 1 0.0017
35 ALVEOLAR PROTEINOSIS 1 0.0017
36 SITTING DISABILITY 1 0.0016
37 MONOCYTOSIS 1 0.0016
38 RECTAL TENESMUS 2 0.0016
39 PERNICIOUS ANAEMIA 1 0.0016
40 GINGIVAL DISCOMFORT 1 0.0015
41 ALCOHOL INTOLERANCE 1 0.0014
42 BITE 1 0.0014
43 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
44 SMALL FIBRE NEUROPATHY 1 0.0014
45 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
46 BLISTER RUPTURE 1 0.0013
47 DISLOCATION OF VERTEBRA 3 0.0013
48 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
49 SUPERINFECTION BACTERIAL 1 0.0013
50 SUFFOCATION FEELING 3 0.0012
51 SENSATION OF PRESSURE 1 0.0011
52 BLOOD ALBUMIN INCREASED 1 0.0011
53 METASTASES TO ADRENALS 1 0.0011
54 SKIN TEST POSITIVE 1 0.0011
55 BLADDER CATHETERISATION 1 0.0010
56 CATHETER SITE ERYTHEMA 2 0.0009
57 HAEMOGLOBINURIA 1 0.0009
58 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
59 ASTHMATIC CRISIS 3 0.0008
60 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
61 SIALOADENITIS 1 0.0007
62 RENAL ARTERY STENOSIS 1 0.0007
63 ALVEOLITIS 1 0.0007
64 CONNECTIVE TISSUE DISORDER 1 0.0007
65 NAIL INFECTION 1 0.0007
66 PANCREATIC ENZYMES INCREASED 1 0.0007
67 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
68 MENTAL FATIGUE 1 0.0007
69 MOUTH INJURY 1 0.0007
70 MASTICATION DISORDER 2 0.0007
71 MEAN CELL VOLUME DECREASED 1 0.0006
72 NASAL ULCER 1 0.0006
73 RASH VESICULAR 3 0.0006
74 SPINAL DEFORMITY 1 0.0006
75 BILIARY DYSKINESIA 1 0.0006
76 ENTERITIS INFECTIOUS 1 0.0006
77 KIDNEY FIBROSIS 1 0.0006
78 SENSITIVITY TO WEATHER CHANGE 3 0.0006
79 APPLICATION SITE DISCOMFORT 1 0.0006
80 TUNNEL VISION 1 0.0005
81 BONE MARROW TRANSPLANT 1 0.0005
82 MOTION SICKNESS 1 0.0005
83 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
84 SUDDEN HEARING LOSS 1 0.0005
85 LYMPHOCYTOSIS 1 0.0005
86 RHINITIS ALLERGIC 2 0.0004
87 CALCINOSIS 1 0.0004
88 ORAL PRURITUS 1 0.0004
89 DISCOURAGEMENT 1 0.0004
90 ESCHERICHIA BACTERAEMIA 1 0.0004
91 INGROWING NAIL 1 0.0004
92 ORAL DISORDER 3 0.0004
93 CATHETER SITE PAIN 1 0.0004
94 HYPERLACTACIDAEMIA 1 0.0004
95 RHINITIS 3 0.0004
96 MOUTH SWELLING 2 0.0003
97 TOOTH DISCOLOURATION 1 0.0003
98 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
99 ATYPICAL PNEUMONIA 1 0.0003
100 BLOOD CREATININE DECREASED 1 0.0003
101 SPUTUM DISCOLOURED 3 0.0003
102 OEDEMA MOUTH 1 0.0003
103 SUSPECTED COVID-19 1 0.0003
104 HAIR GROWTH ABNORMAL 2 0.0003
105 BODY HEIGHT DECREASED 3 0.0003
106 HYPERTHYROIDISM 4 0.0003
107 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
108 BLOOD PHOSPHORUS DECREASED 1 0.0003
109 FOOD INTOLERANCE 1 0.0003
110 AMYLASE INCREASED 1 0.0003
111 LIPASE INCREASED 2 0.0003
112 THYROID MASS 1 0.0003
113 SENSATION OF HEAVINESS 1 0.0003
114 SPINAL PAIN 3 0.0003
115 PROCEDURAL HAEMORRHAGE 1 0.0003
116 RESPIRATORY ACIDOSIS 1 0.0003
117 APPLICATION SITE DISCOLOURATION 1 0.0002
118 ABNORMAL FAECES 2 0.0002
119 ARTHRITIS BACTERIAL 1 0.0002
120 ACCIDENTAL EXPOSURE 1 0.0002
121 SECRETION DISCHARGE 3 0.0002
122 PRODUCT DISPENSING ISSUE 1 0.0002
123 MONOPLEGIA 1 0.0002
124 HEAD DISCOMFORT 4 0.0002
125 WHEELCHAIR USER 1 0.0002
126 EAR DISORDER 1 0.0002
127 PRODUCT DISTRIBUTION ISSUE 2 0.0002
128 LIMB OPERATION 1 0.0002
129 FAECAL INCONTINENCE 1 0.0002
130 MUCOUS STOOLS 1 0.0002
131 SMALL FOR DATES BABY 1 0.0002
132 UPPER LIMB FRACTURE 4 0.0002
133 PRODUCT COLOUR ISSUE 1 0.0002
134 TENDONITIS 3 0.0002
135 VARICOSE VEIN 1 0.0002
136 MALABSORPTION 1 0.0002
137 COMPRESSION FRACTURE 1 0.0002
138 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
139 JAW DISORDER 1 0.0002
140 ASTHENOPIA 1 0.0002
141 SNEEZING 4 0.0002
142 PREMATURE LABOUR 1 0.0002
143 EXERCISE TOLERANCE DECREASED 1 0.0002
144 HEARING IMPAIRED 1 0.0002
145 BLOOD PRESSURE FLUCTUATION 4 0.0002
146 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
147 TENSION 1 0.0002
148 PIGMENTATION DISORDER 1 0.0002
149 LIMB DISCOMFORT 5 0.0002
150 HIATUS HERNIA 2 0.0002
151 APPLICATION SITE VESICLES 1 0.0002
152 PRODUCT PREPARATION ISSUE 1 0.0002
153 HYPOGAMMAGLOBULINAEMIA 1 0.0002
154 FEAR 4 0.0001
155 METASTASES TO LYMPH NODES 1 0.0001
156 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
157 PRODUCT LABEL ISSUE 1 0.0001
158 DERMATITIS 3 0.0001
159 HAND FRACTURE 1 0.0001
160 THERMAL BURN 1 0.0001
161 DIVERTICULUM 1 0.0001
162 METASTASIS 1 0.0001
163 PRODUCT SUPPLY ISSUE 1 0.0001
164 FAECES SOFT 1 0.0001
165 UTERINE LEIOMYOMA 1 0.0001
166 CARDIOMYOPATHY 2 0.0001
167 HYPERTHERMIA 1 0.0001
168 PROCEDURAL COMPLICATION 1 0.0001
169 DEVICE RELATED INFECTION 2 0.0001
170 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
171 MULTIPLE ALLERGIES 1 0.0001
172 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
173 FURUNCLE 1 0.0001
174 BLOOD ALBUMIN DECREASED 1 0.0001
175 GINGIVAL PAIN 1 0.0001
176 SENSORY DISTURBANCE 2 0.0001
177 SENSORY LOSS 1 0.0001
178 POLYURIA 1 0.0001
179 HYPERAESTHESIA 1 0.0001
180 MENSTRUAL DISORDER 1 0.0001
181 FACE OEDEMA 2 0.0001
182 MUSCULOSKELETAL DISCOMFORT 2 0.0001
183 EAR INFECTION 3 0.0001
184 HEAVY MENSTRUAL BLEEDING 1 0.0001
185 CONJUNCTIVITIS 2 0.0001
186 DEFORMITY 1 0.0001
187 PRESCRIBED OVERDOSE 2 0.0001
188 PHARYNGEAL SWELLING 1 0.0001
189 COELIAC DISEASE 1 0.0001
190 THERAPY CHANGE 1 0.0001
191 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
192 BLADDER DISORDER 1 0.0001
193 SALIVARY HYPERSECRETION 1 0.0001
194 TASTE DISORDER 2 0.0001
195 TEMPERATURE INTOLERANCE 1 0.0001
196 EYE DISCHARGE 1 0.0001
197 WEIGHT FLUCTUATION 1 0.0001
198 MUSCULOSKELETAL PAIN 5 0.0001
199 HEREDITARY ANGIOEDEMA 1 0.0001
200 MENSTRUATION DELAYED 1 0.0001
201 OESOPHAGITIS 1 0.0001
202 BLOOD GLUCOSE FLUCTUATION 1 0.0001
203 APPLICATION SITE PAIN 2 0.0001
204 LIVER DISORDER 4 0.0001
205 SKIN INFECTION 1 0.0001
206 PRODUCT AVAILABILITY ISSUE 2 0.0001
207 DERMATITIS CONTACT 1 0.0001
208 MICTURITION URGENCY 1 0.0001
209 MADAROSIS 1 0.0001
210 RASH MACULAR 3 0.0001
211 NASAL CONGESTION 5 0.0001
212 WHEEZING 5 0.0001
213 BACTERAEMIA 1 0.0001
214 WRIST FRACTURE 1 0.0001
215 LOCALISED INFECTION 2 0.0001
216 PRESYNCOPE 2 0.0001
217 VERTIGO 5 0.0001
218 TENDON RUPTURE 1 0.0001
219 HYPERCALCAEMIA 1 0.0001
220 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
221 POISONING 1 0.0001
222 ANOREXIA 1 0.0001
223 ANAPHYLACTIC SHOCK 2 0.0001
224 INFLAMMATION 4 0.0001
225 MUCOSAL INFLAMMATION 2 0.0001
226 BEDRIDDEN 1 0.0001
227 GASTRITIS 2 0.0001
228 DEPRESSED MOOD 4 0.0001
229 FREQUENT BOWEL MOVEMENTS 2 0.0001
230 PSORIATIC ARTHROPATHY 3 0.0001
231 LIMB INJURY 2 0.0001
232 DEVICE MECHANICAL ISSUE 1 0.0001
233 PERIPHERAL COLDNESS 1 0.0001
234 ORAL DISCOMFORT 1 0.0001
235 MASS 1 0.0001
236 DEVICE OCCLUSION 1 0.0001
237 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
238 HYPERSOMNIA 2 0.0001
239 HYPOACUSIS 3 0.0001
240 PARAESTHESIA ORAL 1 0.0001
241 BONE PAIN 4 0.0001
242 SKIN HAEMORRHAGE 1 0.0001
243 HYPOAESTHESIA ORAL 1 0.0001
244 ECONOMIC PROBLEM 1 0.0001
245 SKIN IRRITATION 3 0.0001
246 THYROID DISORDER 1 0.0001
247 BRAIN FOG 1 0.0001
248 OCULAR HYPERAEMIA 3 0.0001
249 PRODUCTIVE COUGH 3 0.0001
250 CYSTITIS 2 0.0001
251 MOVEMENT DISORDER 2 0.0001
252 BLOOD POTASSIUM INCREASED 1 0.0001
253 METASTASES TO BONE 1 0.0001
254 HEART RATE INCREASED 6 0.0001
255 VENTRICULAR TACHYCARDIA 1 0.0001
256 LIP SWELLING 2 0.0001
257 MULTI-ORGAN FAILURE 1 0.0001
258 NERVOUSNESS 3 0.0001
259 LOCAL SWELLING 1 0.0001
260 SYRINGE ISSUE 1 0.0001
261 EOSINOPHILIA 1 0.0001
262 BURNING SENSATION 4 0.0001
263 METASTASES TO LIVER 1 0.0001
264 COLD SWEAT 1 0.0001
265 LYMPHOCYTE COUNT DECREASED 1 0.0001
266 LYMPHADENOPATHY 2 0.0001
267 THIRST 1 0.0001
268 DYSURIA 2 0.0001
269 CHEST PAIN 10 0.0001
270 ASTHMA 6 0.0001
271 INCREASED APPETITE 1 0.0001
272 GLAUCOMA 1 0.0001
273 DRUG INTOLERANCE 5 0.0001
274 ERUCTATION 1 0.0001
275 EAR PAIN 1 0.0001
276 CHOKING 1 0.0001
277 HAEMATOCRIT DECREASED 1 0.0001
278 PREGNANCY 1 0.0000
279 SPINAL FRACTURE 1 0.0000
280 FEEDING DISORDER 1 0.0000
281 DYSKINESIA 2 0.0000
282 INJURY ASSOCIATED WITH DEVICE 1 0.0000
283 FEELING HOT 3 0.0000
284 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
285 ABDOMINAL PAIN UPPER 10 0.0000
286 HYPERSENSITIVITY 9 0.0000
287 INTENTIONAL DRUG MISUSE 1 0.0000
288 BACK PAIN 11 0.0000
289 IRRITABLE BOWEL SYNDROME 1 0.0000
290 PRURITUS GENERALISED 1 0.0000
291 SWELLING FACE 3 0.0000
292 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
293 MUSCULOSKELETAL STIFFNESS 4 0.0000
294 INFUSION RELATED REACTION 3 0.0000
295 ANGIOEDEMA 2 0.0000
296 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
297 RASH MACULO-PAPULAR 1 0.0000
298 ORAL PAIN 1 0.0000
299 RASH PAPULAR 1 0.0000
300 THERAPY NON-RESPONDER 2 0.0000
301 PANCREATITIS ACUTE 1 0.0000
302 COMA 2 0.0000
303 THERAPY INTERRUPTED 3 0.0000
304 MOBILITY DECREASED 3 0.0000
305 FEELING ABNORMAL 10 0.0000
306 JOINT SWELLING 5 0.0000
307 EMOTIONAL DISTRESS 5 0.0000
308 HYPOGLYCAEMIA 2 0.0000
309 NEURALGIA 1 0.0000
310 INJECTION SITE URTICARIA 1 0.0000
311 BRONCHITIS 3 0.0000
312 EXTRAPYRAMIDAL DISORDER 1 0.0000
313 EPISTAXIS 3 0.0000
314 HYPOAESTHESIA 6 0.0000
315 CELLULITIS 2 0.0000
316 GASTRIC CANCER 1 0.0000
317 CARDIOVASCULAR DISORDER 1 0.0000
318 BLOOD PRESSURE INCREASED 6 0.0000
319 HYPOPHAGIA 1 0.0000
320 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
321 ILLNESS 4 0.0000
322 ECZEMA 2 0.0000
323 ANHEDONIA 1 0.0000
324 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
325 BLOOD BILIRUBIN INCREASED 1 0.0000
326 THROAT TIGHTNESS 1 0.0000
327 RASH PRURITIC 2 0.0000
328 PNEUMONITIS 1 0.0000
329 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
330 SKIN LESION 1 0.0000
331 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
332 MEMORY IMPAIRMENT 5 0.0000
333 HAEMATOCHEZIA 2 0.0000
334 ABNORMAL DREAMS 1 0.0000
335 ANAPHYLACTIC REACTION 2 0.0000
336 PROCEDURAL PAIN 1 0.0000
337 WOUND 1 0.0000
338 BLISTER 2 0.0000
339 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
340 TARDIVE DYSKINESIA 1 0.0000
341 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
342 PAIN IN JAW 1 0.0000
343 FLATULENCE 2 0.0000
344 INTENTIONAL DOSE OMISSION 1 0.0000
345 SOMNOLENCE 7 0.0000
346 EYE IRRITATION 2 0.0000
347 PANCREATIC CARCINOMA 1 0.0000
348 DYSSTASIA 1 0.0000
349 DYSPHONIA 2 0.0000
350 PRURITUS 13 0.0000
351 BLOOD POTASSIUM DECREASED 1 0.0000
352 PLEURAL EFFUSION 2 0.0000
353 VISUAL IMPAIRMENT 4 0.0000
354 EXPOSURE DURING PREGNANCY 2 0.0000
355 COUGH 9 0.0000
356 CARDIAC DISORDER 3 0.0000
357 SWELLING 3 0.0000
358 NERVOUS SYSTEM DISORDER 1 0.0000
359 SWOLLEN TONGUE 1 0.0000
360 HEAD INJURY 1 0.0000
361 MIGRAINE 3 0.0000
362 HYPERHIDROSIS 4 0.0000
363 PAIN IN EXTREMITY 9 0.0000
364 OSTEONECROSIS 1 0.0000
365 STAPHYLOCOCCAL INFECTION 1 0.0000
366 FEBRILE NEUTROPENIA 2 0.0000
367 VISUAL ACUITY REDUCED 1 0.0000
368 SKIN DISORDER 1 0.0000
369 GAIT INABILITY 1 0.0000
370 CHEST DISCOMFORT 3 0.0000
371 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
372 SINUSITIS 3 0.0000
373 NIGHTMARE 1 0.0000
374 WEIGHT DECREASED 8 0.0000
375 CRYING 1 0.0000
376 C-REACTIVE PROTEIN INCREASED 1 0.0000
377 NASOPHARYNGITIS 5 0.0000
378 INFLUENZA 3 0.0000
379 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
380 ABNORMAL BEHAVIOUR 1 0.0000
381 DISORIENTATION 1 0.0000
382 DEVICE BREAKAGE 1 0.0000
383 NEUTROPHIL COUNT DECREASED 1 0.0000
384 ERYTHEMA 5 0.0000
385 ARTHRALGIA 10 0.0000
386 POLLAKIURIA 1 0.0000
387 HEADACHE 15 0.0000
388 CARDIO-RESPIRATORY ARREST 1 0.0000
389 URTICARIA 4 0.0000
390 ABDOMINAL DISCOMFORT 4 0.0000
391 WITHDRAWAL SYNDROME 1 0.0000
392 PRODUCT DOSE OMISSION ISSUE 7 0.0000
393 HYPERTENSION 5 0.0000
394 BALANCE DISORDER 2 0.0000
395 SEPTIC SHOCK 1 0.0000
396 MENTAL DISORDER 1 0.0000
397 MALAISE 10 0.0000
398 INSOMNIA 6 0.0000
399 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
400 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
401 TINNITUS 1 0.0000
402 SKIN DISCOLOURATION 1 0.0000
403 ADVERSE EVENT 2 0.0000
404 HYPOKALAEMIA 1 0.0000
405 OROPHARYNGEAL PAIN 2 0.0000
406 RENAL DISORDER 1 0.0000
407 COGNITIVE DISORDER 1 0.0000
408 FALL 7 0.0000
409 NEUROPATHY PERIPHERAL 2 0.0000
410 DISEASE RECURRENCE 1 0.0000
411 MULTIPLE SCLEROSIS 1 0.0000
412 BLOOD GLUCOSE DECREASED 1 0.0000
413 CONTUSION 2 0.0000
414 RASH 9 0.0000
415 ALOPECIA 4 0.0000
416 PYREXIA 7 0.0000
417 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
418 DRY EYE 1 0.0000
419 ABDOMINAL DISTENSION 2 0.0000
420 SPEECH DISORDER 1 0.0000
421 PANCREATITIS 1 0.0000
422 DIZZINESS 9 0.0000
423 NECK PAIN 1 0.0000
424 WEIGHT INCREASED 4 0.0000
425 EYE PAIN 1 0.0000
426 DYSPNOEA 10 0.0000
427 HERPES ZOSTER 1 0.0000
428 LETHARGY 1 0.0000
429 PRODUCT SUBSTITUTION ISSUE 1 0.0000
430 DECREASED APPETITE 4 0.0000
431 ABDOMINAL PAIN 4 0.0000
432 COVID-19 3 0.0000
433 ILL-DEFINED DISORDER 1 0.0000
434 DISCOMFORT 1 0.0000
435 PAIN 10 0.0000
436 ASTHENIA 6 0.0000
437 GAIT DISTURBANCE 3 0.0000
438 DIARRHOEA 10 0.0000
439 RHINORRHOEA 1 0.0000
440 DEEP VEIN THROMBOSIS 1 0.0000
441 BLOOD PRESSURE DECREASED 1 0.0000
442 DEHYDRATION 2 0.0000
443 DRY SKIN 2 0.0000
444 PRODUCT QUALITY ISSUE 2 0.0000
445 NEUTROPENIA 2 0.0000
446 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
447 INJURY 1 0.0000
448 FATIGUE 11 0.0000
449 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
450 ANXIETY 4 0.0000
451 INFECTION 2 0.0000
452 CONSTIPATION 3 0.0000
453 RESPIRATORY FAILURE 1 0.0000
454 UNDERDOSE 1 0.0000
455 AGITATION 1 0.0000
456 DYSGEUSIA 1 0.0000
457 HOT FLUSH 1 0.0000
458 INJECTION SITE SWELLING 1 0.0000
459 PERIPHERAL SWELLING 2 0.0000
460 DRUG DOSE OMISSION BY DEVICE 1 0.0000
461 ARTHRITIS 1 0.0000
462 NAUSEA 10 0.0000
463 OFF LABEL USE 11 0.0000
464 INJECTION SITE HAEMORRHAGE 1 0.0000
465 THROMBOSIS 1 0.0000
466 PNEUMONIA 4 0.0000
467 DRY MOUTH 1 0.0000
468 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
469 TREATMENT FAILURE 1 0.0000
470 TREMOR 2 0.0000
471 COMPLETED SUICIDE 1 0.0000
472 URINARY TRACT INFECTION 2 0.0000
473 PRODUCT STORAGE ERROR 1 0.0000
474 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
475 TACHYCARDIA 1 0.0000
476 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
477 GASTROINTESTINAL DISORDER 1 0.0000
478 DEVICE ISSUE 1 0.0000
479 ADVERSE DRUG REACTION 1 0.0000
480 NO ADVERSE EVENT 2 0.0000
481 PULMONARY EMBOLISM 1 0.0000
482 DYSPEPSIA 1 0.0000
483 HYPOTENSION 2 0.0000
484 FLUSHING 1 0.0000
485 INJECTION SITE PAIN 3 0.0000
486 HAEMOGLOBIN DECREASED 1 0.0000
487 HAEMORRHAGE 1 0.0000
488 DRUG INEFFECTIVE 12 0.0000
489 SEIZURE 1 0.0000
490 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
491 PALPITATIONS 1 0.0000
492 CHILLS 1 0.0000
493 INJECTION SITE ERYTHEMA 1 0.0000
494 LOSS OF CONSCIOUSNESS 1 0.0000
495 PSORIASIS 1 0.0000
496 VISION BLURRED 1 0.0000
497 VOMITING 3 0.0000
498 PARAESTHESIA 1 0.0000
499 DRUG INTERACTION 1 0.0000
500 TOXICITY TO VARIOUS AGENTS 1 0.0000
501 CEREBROVASCULAR ACCIDENT 1 0.0000
502 MYALGIA 1 0.0000
503 MYOCARDIAL INFARCTION 1 0.0000
504 MUSCLE SPASMS 1 0.0000
505 PRODUCT USE ISSUE 1 0.0000
506 BLOOD GLUCOSE INCREASED 1 0.0000
507 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
508 DEPRESSION 1 0.0000
509 INCORRECT DOSE ADMINISTERED 1 0.0000
510 CONDITION AGGRAVATED 1 0.0000